Concord Wealth Partners’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-315
Closed -$18K 1221
2022
Q1
$18K Sell
315
-41
-12% -$2.11K ﹤0.01% 648
2021
Q4
$19K Buy
356
+83
+30% +$4.44K ﹤0.01% 652
2021
Q3
$14K Sell
273
-131
-32% -$6.79K 0.01% 422
2021
Q2
$24K Sell
404
-92
-19% -$5.69K 0.01% 466
2021
Q1
$32K Buy
496
+486
+4,860% +$29.8K 0.01% 406
2020
Q4
$1K Buy
+10
New +$510 ﹤0.01% 590

Other funds holding ACA

Concord Wealth Partners's ACA Position: Q2 2022 in Review

Concord Wealth Partners sold out of Arcosa (ACA) in Q2 2022, closing a stake of 315 shares — an estimated $18K sold.

Concord Wealth Partners first reported a position in ACA in Q4 2020 and held it in 6 quarters. The position peaked at $32K in Q1 2021. 247 funds tracked by Wall St. Rank hold ACA as of Q2 2022.

  • Concord Wealth Partners reported no remaining Arcosa position as of Q2 2022 after selling out during the quarter.
  • Concord Wealth Partners sold 315 Arcosa shares in Q2 2022, an estimated $18K.
  • Concord Wealth Partners first reported a position in Arcosa in Q4 2020 and held it in 6 quarters.
  • Concord Wealth Partners's Arcosa position peaked at $32K in Q1 2021.
  • 247 funds tracked by Wall St. Rank held Arcosa as of Q2 2022.

Based on Concord Wealth Partners's 13F filing for Q2 2022, filed 4 Aug 2022.